19 May 2013
Keywords: trimeris, reveals, strategic, plan, biopharmaceutical, firm, announced
Article | 17 December 2007
US biopharmaceutical firm Trimeris has announced its strategic plan for 2008 that is designed to maximize cash flows from its anti-HIV ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 December 2007
17 May 2013
© 2013 thepharmaletter.com